Quoin Pharmaceuticals Ltd DRC (QNRX)

Quoin Pharmaceuticals Ltd DRC (QNRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $21.9M; returns 1 day +0.2%, 1 week +3.1%, 1 year -70.0%.

Quoin Pharmaceuticals Ltd (QNRX) is a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing therapeutic products for rare and orphan diseases. The company currently generates no product revenue, with its business model centered on advancing its drug pipeline through clinical development to regulatory approval and subsequent commercialization.

Groups QNRX belongs to

• Rare Diseases
• Clinical Stage Biotech
• Biotechnology
• Pharmaceuticals
• Healthcare
• Dermatology
• Clinical Stage
• Lymphatic Malformations
• R&D

QNRX financial model: income statement, cash flow and balance sheet